MNKD Next Earnings Date Notes

— MannKind (MNKD) is a biopharmaceutical company focused primarily on the development & commercialization of inhaled therapeutic products for patients with diseases such as diabetes & pulmonary arterial hypertension. Its flagship product, Afrezza®, is a rapid-acting inhaled insulin for adults with diabetes, designed to address unmet needs in mealtime glucose control. Additionally, MannKind is advancing Tyvaso DPI® (for pulmonary arterial hypertension) in collaboration with United Therapeutics, which represents an important growth opportunity. For investors listening to MNKD’s earnings calls, key business metrics to track include Afrezza® prescription & revenue trends, progress/commercial performance of Tyvaso DPI®, partnerships or licensing agreements, R&D pipeline advances, and overall cash burn or financial runway. Observing updates on commercial partnerships, net sales, and regulatory milestones will help gauge MannKind’s ability to expand its product reach and manage costs. Additionally, monitoring gross margin improvements & management commentary on strategic priorities provides insight into the company’s path to profitability and long-term sustainability. The next projected earnings date for MNKD is 11/4/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

MNKD Next Earnings Date FAQ

On this page we presented the MNKD Next Earnings Date information for MannKind along with recent past earnings dates. For Q2 of 2026, MNKD reported earnings of -0.010/share, with the earnings report taking place on 8/5/2026. For Q1 of 2026, MNKD reported earnings of -0.020/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, MNKD reported earnings of 0.010/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, MNKD reported earnings of 0.070/share, with the earnings report taking place on 11/5/2025. For Q2 of 2025, MNKD reported earnings of 0.050/share, with the earnings report taking place on 8/6/2025. Based on these past earnings dates, the projected next earnings date for MNKD is 11/4/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as MannKind. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to MannKind shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research MannKind next earnings dates as well as any other stock out there in our coverage universe, to see when the next MNKD earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up MNKD's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the MNKD next earnings date.